These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36403197)

  • 21. Effects of microRNA-513b on cell proliferation, apoptosis, invasion, and migration by targeting HMGB3 through regulation of mTOR signaling pathway in non-small-cell lung cancer.
    Wang J; Sheng Z; Cai Y
    J Cell Physiol; 2019 Jul; 234(7):10934-10941. PubMed ID: 30623409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevation of EIF4G1 promotes non-small cell lung cancer progression by activating mTOR signalling.
    Lu Y; Yu S; Wang G; Ma Z; Fu X; Cao Y; Li Q; Xu Z
    J Cell Mol Med; 2021 Mar; 25(6):2994-3005. PubMed ID: 33523588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
    Luo F; Zhao Y; Liu J
    Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of EI2BL promoted human non-small cell lung cancer progression by inducing cell EMT phenotype.
    Li HR; Qiu BQ; Gao J; Jin C; Jiang JH; Ding JY
    J Clin Pathol; 2020 Mar; 73(3):139-146. PubMed ID: 31586937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761.
    Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR‑802 inhibits the aggressive behaviors of non‑small cell lung cancer cells by directly targeting FGFR1.
    Zhang J; Li J; Li S; Zhou C; Qin Y; Li X
    Int J Oncol; 2019 Jun; 54(6):2211-2221. PubMed ID: 30942425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
    Sun M; Liu XH; Wang KM; Nie FQ; Kong R; Yang JS; Xia R; Xu TP; Jin FY; Liu ZJ; Chen JF; Zhang EB; De W; Wang ZX
    Mol Cancer; 2014 Mar; 13():68. PubMed ID: 24655544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA BX357664 inhibits the proliferation and invasion of non-small cell lung cancer cells.
    Yang J; Du YM; Li B
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):660-669. PubMed ID: 30720174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB; Wang SX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway.
    Xing Y; Meng Q; Chen X; Zhao Y; Liu W; Hu J; Xue F; Wang X; Cai L
    Oncotarget; 2016 May; 7(21):30479-91. PubMed ID: 27058415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caspase Recruitment Domain Containing Protein 9 Suppresses Non-Small Cell Lung Cancer Proliferation and Invasion via Inhibiting MAPK/p38 Pathway.
    Pan L; Tan Y; Wang B; Qiu W; Yin Y; Ge H; Zhu H
    Cancer Res Treat; 2020 Jul; 52(3):867-885. PubMed ID: 32164050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibin βA is an independent prognostic factor that promotes invasion via Hippo signaling in non‑small cell lung cancer.
    Zhang Y; Yan S; Li Y; Zhang J; Luo Y; Li P; Yang Y; Li Y; Huang Y; Wang E
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34505633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway.
    Shi J; Yang C; An J; Hao D; Liu C; Liu J; Sun J; Jiang J
    J Exp Clin Cancer Res; 2021 Apr; 40(1):148. PubMed ID: 33931086
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Chang Q; Zhou X; Mao H; Feng J; Wu X; Zhang Z; Hu Z
    Biomol Biomed; 2024 Sep; 24(5):1216-1230. PubMed ID: 38501918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell cycle-related and expression-elevated protein in tumor overexpression is associated with proliferation behaviors and poor prognosis in non-small-cell lung cancer.
    Li W; Zheng G; Xia J; Yang G; Sun J; Wang X; Wen M; Sun Y; Zhang Z; Jin F
    Cancer Sci; 2018 Apr; 109(4):1012-1023. PubMed ID: 29397041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer.
    Liu XH; Liu ZL; Sun M; Liu J; Wang ZX; De W
    BMC Cancer; 2013 Oct; 13():464. PubMed ID: 24103700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA ASAP1-IT1 promotes cell proliferation, invasion and metastasis through the PTEN/AKT signaling axis in non-small cell lung cancer.
    Zhang L; Shi SB; Zhu Y; Qian TT; Wang HL
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):142-149. PubMed ID: 29364481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FOXM1-regulated ZIC2 promotes the malignant phenotype of renal clear cell carcinoma by activating UBE2C/mTOR signaling pathway.
    Lv Z; Wang M; Hou H; Tang G; Xu H; Wang X; Li Y; Wang J; Liu M
    Int J Biol Sci; 2023; 19(11):3293-3306. PubMed ID: 37496990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.